幼儿着色性干皮病继发下唇鳞癌1例

doi:10.13591/j.cnki.kqyx.2025.03.009

口腔医学 ›› 2025, Vol. 45 ›› Issue (3): 210-212.doi: 10.13591/j.cnki.kqyx.2025.03.009

幼儿着色性干皮病继发下唇鳞癌1例

李世勇¹, 吴勇¹^,², 张馨³, 马文¹^,², 王思航¹^,², 付帅¹^,²()

1 昆明医科大学附属口腔医院口腔颌面外科,云南昆明(650106)
2 云南省口腔医学重点实验室,云南昆明(650106)
3 云南师范大学校医院口腔科,云南昆明(650500)

收稿日期:2024-05-13 出版日期:2025-03-28 发布日期:2025-03-18
通讯作者: 付帅 E-mail:314849100@qq.com
基金资助:
云南省科技厅-昆医联合专项(202201AY070001-176)

A case of squamous cell carcinoma of the lower lip secondary to xeroderma pigmentosum in a child

LI Shiyong¹, WU Yong¹^,², ZHANG Xin³, MA Wen¹^,², WANG Sihang¹^,², FU Shuai¹^,²()

Department of Oral and Maxillofacial Surgery, Stomatology Hospital of Kunming Medical University, Kunming 650106, China

Received:2024-05-13 Online:2025-03-28 Published:2025-03-18
Contact: FU Shuai E-mail:314849100@qq.com

摘要/Abstract

摘要：

着色性干皮病(xeroderma pigmentosum, XP)是一种罕见的常染色体隐性遗传疾病,与XP基因的变异有关,常继发恶性肿瘤。该文对1例着色性干皮病继发下唇鳞癌的幼儿病例进行报道,并通过相关文献复习,对着色性干皮病的临床特点、发生机制、临床病理表现及预后进行讨论。

关键词: 着色性干皮病, 鳞癌, 颌面部

Abstract:

Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder related to XP gene variation, often causing secondary malignant tumors. This article reports a case of a young child with secondary squamous cell carcinoma of the lower lip caused by xeroderma pigmentosum. Through a review of relevant literature, the clinical characteristics, pathogenesis, clinical pathological manifestations, and prognosis of XP are discussed.

Key words: xeroderma pigmentosum, squamous cell carcinoma, maxillofacial region

中图分类号:

R758.58

李世勇, 吴勇, 张馨, 马文, 王思航, 付帅. 幼儿着色性干皮病继发下唇鳞癌1例[J]. 口腔医学, 2025, 45(3): 210-212.

LI Shiyong, WU Yong, ZHANG Xin, MA Wen, WANG Sihang, FU Shuai. A case of squamous cell carcinoma of the lower lip secondary to xeroderma pigmentosum in a child[J]. Stomatology, 2025, 45(3): 210-212.

图/表 2

参考文献 19

[1]	刘华联. 着色性干皮症继发颌面部恶性肿瘤的临床特点及其手术治疗[J]. 口腔医学, 2016, 36(2): 150-153.
[2]	王雪丽, 贾俊, 赵怡芳. 着色性干皮病合并唇、舌癌1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2010, 8(6): 574-576.
[3]	蔡微, 黄卫东. 类着色性干皮病伴面部基底细胞癌及鳞状细胞癌1例[J]. 中国皮肤性病学杂志, 2016, 30(1): 68-69.
[4]	Weon JL, Glass DA 2nd. Novel therapeutic approaches to xeroderma pigmentosum[J]. Br J Dermatol, 2019, 181(2): 249-255. doi: 10.1111/bjd.17253 pmid: 30265743
[5]	Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum[J]. Nature, 1968, 218(5142): 652-656.
[6]	Mu H, Geacintov NE, Broyde S, et al. Molecular basis for damage recognition and verification by XPC-RAD23B and TFIIH in nucleotide excision repair[J]. DNA Repair (Amst), 2018, 71: 33-42.
[7]	Kusakabe M, Onishi Y, Tada H, et al. Mechanism and regulation of DNA damage recognition in nucleotide excision repair[J]. Genes Environ, 2019, 41: 2.
[8]	郭鱼, 陈俊杰, 岑瑛. 着色性干皮病诊治现状与展望[J]. 西部医学, 2019, 31(7): 1145-1148.
[9]	Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases[J]. Arch Dermatol, 1987, 123(2): 241-250. doi: 10.1001/archderm.123.2.241 pmid: 3545087
[10]	郑金锋, 王丽, 刘翠杰. 幼儿着色性干皮病伴角化棘皮瘤1例[J]. 中国麻风皮肤病杂志, 2014, 30(7): 432-433.
[11]	孙景英, 于世荣, 普雄明, 等. 着色性干皮病继发基底细胞癌一例[J]. 中国麻风皮肤病杂志, 2016, 32(3): 175-176.
[12]	Rezvani HR, Mazurier F, Morice-Picard F, et al. Xeroderma pigmentosum: Clues to understanding cancer initiation[J]. Dermatol Sin, 2010, 28(3): 93-101.
[13]	姚婉玉, 唐秀生. 着色性干皮病并发鳞状细胞癌一例[J]. 实用皮肤病学杂志, 2017, 10(5): 310-312, 315.
[14]	Mahindra P, DiGiovanna JJ, Tamura D, et al. Skin cancers, blindness, and anterior tongue mass in African brothers[J]. J Am Acad Dermatol, 2008, 59(5): 881-886. doi: 10.1016/j.jaad.2008.06.030 pmid: 19119101
[15]	Mandal S, Jain S, Mandal AK. Xeroderma pigmentosa with basal cell carcinoma and coexistent multicentric neurofibroma on face[J]. Pathology, 2010, 42(3): 290-291.
[16]	姬腾达, 邱海霞, 曾晶, 等. 着色性干皮病诊疗进展[J]. 中国激光医学杂志, 2019, 28(2): 112-118.
[17]	Chidzonga MM, Mahomva L, Makunike-Mutasa R, et al. Xeroderma pigmentosum: A retrospective case series in Zimbabwe[J]. J Oral Maxillofac Surg, 2009, 67(1): 22-31.
[18]	Schaffer JV, Orlow SJ. Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: Report of two cases and review of the literature[J]. Dermatology, 2011, 223(2): 97-103.
[19]	Messaoud O, Ben Rekaya M, Jerbi M, et al. The experience of a Tunisian referral centre in prenatal diagnosis of Xeroderma pigmentosum[J]. Public Health Genomics, 2013, 16(5): 251-254. doi: 10.1159/000354584 pmid: 24021614

幼儿着色性干皮病继发下唇鳞癌1例

A case of squamous cell carcinoma of the lower lip secondary to xeroderma pigmentosum in a child

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 19

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王盼, 吕炯, 朱慧勇. 靶向脂代谢逆转头颈鳞癌治疗耐药性的研究进展[J]. 口腔医学, 2024, 44(9): 705-709.
[2]	熊轲, 张昊, 胡图强. 大黄素通过调节自噬抑制口腔鳞状细胞癌细胞的增殖[J]. 口腔医学, 2024, 44(8): 602-608.
[3]	孙昕奕, 潘玥彤, 陆欣悦, 吕中静, 袁健, 李家锋, 石欢. PTK7在口腔鳞癌中的表达分析及其生物学功能研究[J]. 口腔医学, 2024, 44(4): 268-275.
[4]	魏志峰, 杨彤彤, 王靖鸿. 影响颌面部发育的上气道阻塞相关因素的研究进展[J]. 口腔医学, 2023, 43(6): 573-576.
[5]	邱波,王冠楠,谷艳娇,黄克强,苏荣健,胡静. 葡萄糖调节蛋白78对顺铂治疗舌鳞癌细胞增殖、迁移和侵袭的影响[J]. 口腔医学, 2023, 43(5): 400-406.
[6]	杨霞, 叶庆元, 宋昌龙, 侯锐, 杨耀武, 魏建华. 第一口综合征诊断与治疗的研究进展[J]. 口腔医学, 2023, 43(2): 188-192.
[7]	佟雪溪, 赵刚. miR-191-5p通过靶向TJP1调控Cal-27细胞增殖、侵袭和迁移的体外研究[J]. 口腔医学, 2023, 43(11): 981-988.
[8]	傅梦蝶, 朱丹吉, 杨国利, 姜治伟. 光遗传学技术在口腔医学中的应用进展[J]. 口腔医学, 2022, 42(4): 354-357.
[9]	郭松松, 张平, 程杰, 江宏兵. 数字化技术在口腔颌面部创伤治疗中的应用及展望[J]. 口腔医学, 2022, 42(1): 36-41.
[10]	白露张丽丽吴琳. 咬合板对颞下颌关节紊乱病相关颌面部疼痛的影响[J]. , 2019, 39(5): 472-476.
[11]	季叶枫于洋苗利民杨建荣袁华. 长链非编码RNA MEG3对头颈鳞状细胞癌增殖和侵袭的影响[J]. , 2019, 39(5): 400-403.
[12]	李康谢春周姮武斌. 伴与不伴糖尿病的口腔颌面部多间隙感染的临床诊治研究[J]. , 2019, 39(3): 231-234.
[13]	陈钱林慧于敬伟李国林. 丹参素在体外条件下对口腔鳞癌细胞 CAL-27抑制作用的研究[J]. , 2019, 39(2): 113-116.
[14]	丁磊曹俊鲁勇胡黎萍徐明耀. 311例口腔颌面部间隙感染患者的回顾性分析[J]. , 2019, 39(2): 121-125.
[15]	侯春宁张雪松李国林. 川陈皮素对口腔鳞状细胞癌细胞Cal-27增殖、迁移和侵袭的影响[J]. , 2018, 38(6): 481-484.